E-Pub Full Text Articles

Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients

Author(s): Xia Li*, Dianxuan Guo, Hualan Zhou, Youdong Hu, Xiang Fang and Ying Chen
Pages: 1-12 (12)
Exosomes and Exosomal microRNAs in Age-associated Stroke

Author(s): Xiang Wang, Changmei HuangFu, Xiudeng Zhu, Jiehong Liu, Xinqin Gong, Qunwen Pan* and Xiaotang Ma
Pages: 1-14 (14)
Blood-brain Barrier Dysfunction and Extension of Time Window for Thrombolysis: A Limitation not Evaluated

Author(s): Antonio Siniscalchi*, Roman Sztajzel, Sean Murphy, Giovambattista De Sarro and Luca Gallelli
Pages: 1-2 (2)
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)

Author(s): Jiangping Gao*, Liuhuan Huang and Jianli Wang
Pages: 1-7 (7)
Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments

Author(s): Vasilios G. Athyros*, Charalambos Koumaras and George Sfikas
Pages: 1-2 (2)
Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia

Author(s): Vasilios G. Athyros, Chrysoula Boutari, Konstantinos Imprialos and Michael Doumas
Pages: 1-2 (2)
Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients

Author(s): Rigas G. Kalaitzidis*, Olga Balafa, Evangelia Dounousi, Dimitrios Stagikas and Vasilios Tsimihodimos
Pages: 1-7 (7)
Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways

Author(s): Denise Coutinho de Miranda, Gabriela de Oliveira Faria, Milla Marques Hermidorff, Fernanda Cacilda dos Santos Silva, Leonardo Vinícius Monteiro de Assis and Mauro César Isoldi*
Pages: 1-26 (26)
Cardioprotective Effects of Natural Products via the Nrf2 Signaling Pathway

Author(s): Rasool Tavakoli, Jamshid Tabeshpour, Javad Asili, Abolfazl Shakeri* and Amirhossein Sahebkar
Pages: 1-17 (17)
Diabetic Cardiomyopathy: Clinical and Metabolic Approach

Author(s): Dragan B. Djordjevic*, Goran Koracevic, Aleksandar D. Djordjevic and Dragan B. Lovic*
Pages: 1-12 (12)
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Author(s): Georgios Sfikas*, Michael Psallas, Charalambos Koumaras, Konstantinos Imprialos, Evangelos Perdikakis, Michael Doumas, Olga Giouleme, Asterios Karagiannis and Vasilios G. Athyros
Pages: 1-10 (10)
Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Author(s): Emir Muzurović*, Brigita Smolović, Snežana Vujošević and Milan Petakov
Pages: 1-3 (3)
Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study

Author(s): Silvia Lai*, Marco Mangiulli, Adolfo M Perrotta, Antonietta Gigante, Ludovica Napoleoni, Elena Cipolloni, Anna P Mitterhofer, Maria L Gasperini, Maurizio Muscaritoli, Rosario Cianci, Antonello Giovannetti, Fabiana Falco, Daniela Mastroluca and Sandro Mazzaferro
Pages: 1-9 (9)
Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis

Author(s): Marco De Carlo*, Giovanni Di Minno, Tobias Sayre, Mir Sohail Fazeli, Gaye Siliman and Claudio Cimminiello
Pages: 1-14 (14)
Have we Learnt all from IMPROVE-IT? Part II. Subanalyses of the Effects of Ezetimibe Added to Statin Therapy on Selected Clinical and Laboratory Outcomes, Cost-Effectiveness, Guideline, and Clinical Implications

Author(s): Zlatko Fras* and Dimitri P. Mikhailidis
Pages: 1-18 (18)
Have we Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease)

Author(s): Zlatko Fras* and Dimitri P. Mikhailidis
Pages: 1-18 (18)

E-Pub Full Text Articles

Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients

Exosomes and Exosomal microRNAs in Age-associated Stroke

Blood-brain Barrier Dysfunction and Extension of Time Window for Thrombolysis: A Limitation not Evaluated

Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)

Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments

Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia

Adherence to Treatment, Arterial Stiffness and Cognitive Function in Irbesartan- Treated Newly Diagnosed Hypertensive Patients

Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways

Cardioprotective Effects of Natural Products via the Nrf2 Signaling Pathway

Diabetic Cardiomyopathy: Clinical and Metabolic Approach

Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?

Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study

Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis

Have we Learnt all from IMPROVE-IT? Part II. Subanalyses of the Effects of Ezetimibe Added to Statin Therapy on Selected Clinical and Laboratory Outcomes, Cost-Effectiveness, Guideline, and Clinical Implications

Have we Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease)